Precision medicine is of substantial significance in contemporary medicine as it enables targeted interventions for a variety of diseases with a relatively low probability of side - effects. Nucleic ...
Aptamer Group plc (AIM: APTA), the developer of novel Optimer ® binders to enable innovation in the life sciences industry, has signed an agreement with Timser Group, a pharmaceutical company focused ...
Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results